Gabapentin and Plasma Donation: Why Most Centers Restrict Donation During Treatment
Gabapentin (and its prodrug gabapentin enacarbil) is generally a deferral medication at plasma collection centers.
Rationale
- Analytical interference: Gabapentin may alter plasma protein electrophoresis, coagulation assays, or viral marker immunoassays, compromising product quality testing.
- Pharmacodynamic concern: Gabapentin binds α2δ subunit of voltage-gated calcium channels; theoretical risk of altering recipient neurophysiology (though plasma fractionation dilutes/denatures).
- Regulatory precaution: FDA/EMA guidance treats gabapentin as a “medication affecting plasma safety/quality” pending definitive data.
Center Policy
- Most centers (CSL Plasma, BioLife, Octapharma, Grifols) require washout period (typically 48 hours to 7 days after last dose) before donation.
- Disclose all medications at screening; staff will apply current SOP.
- Do not stop prescribed gabapentin without prescriber approval.
If deferred, ask for written policy and re-evaluation timeline.
Urine Therapy - Related Articles
- Burning Urination at 38 Weeks Pregnant: Causes and Relief Strategies
- Urine in the Rectum: Medical Risks and Safety Considerations
- Newborn Metabolic Screening: Understanding Urine Tests and Early Detection
- Trichomoniasis Testing at Planned Parenthood: Urine vs. Swab Methods Compared
- Ciprofloxacin for Non-Gonococcal Urethritis (NGU): Effectiveness and Alternatives
- Protein and Bilirubin in Urine: Causes, Significance, and Workup
- Managing Diarrhea After Right Hemicolectomy: Loperamide & Options
